CN112205507A - 一种能改善睡眠的组合物、保健食品、药物制剂及其制备方法与应用 - Google Patents
一种能改善睡眠的组合物、保健食品、药物制剂及其制备方法与应用 Download PDFInfo
- Publication number
- CN112205507A CN112205507A CN202011060590.9A CN202011060590A CN112205507A CN 112205507 A CN112205507 A CN 112205507A CN 202011060590 A CN202011060590 A CN 202011060590A CN 112205507 A CN112205507 A CN 112205507A
- Authority
- CN
- China
- Prior art keywords
- parts
- composition
- sleep
- gamma
- theanine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 48
- 239000000825 pharmaceutical preparation Substances 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 235000013402 health food Nutrition 0.000 title claims abstract description 12
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 64
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 claims abstract description 54
- 239000000284 extract Substances 0.000 claims abstract description 33
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 32
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 32
- 229940026510 theanine Drugs 0.000 claims abstract description 27
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims abstract description 26
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims abstract description 26
- 229940022405 astaxanthin Drugs 0.000 claims abstract description 26
- 235000013793 astaxanthin Nutrition 0.000 claims abstract description 26
- 239000001168 astaxanthin Substances 0.000 claims abstract description 26
- 229960003035 magnesium gluconate Drugs 0.000 claims abstract description 25
- 239000001755 magnesium gluconate Substances 0.000 claims abstract description 25
- 235000015778 magnesium gluconate Nutrition 0.000 claims abstract description 25
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 claims abstract description 25
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 18
- 239000003814 drug Substances 0.000 claims abstract description 12
- 240000000759 Lepidium meyenii Species 0.000 claims abstract description 10
- 235000000421 Lepidium meyenii Nutrition 0.000 claims abstract description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 10
- 235000008434 ginseng Nutrition 0.000 claims abstract description 10
- 235000012902 lepidium meyenii Nutrition 0.000 claims abstract description 10
- 241000282994 Cervidae Species 0.000 claims abstract description 8
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims abstract description 8
- 240000000249 Morus alba Species 0.000 claims abstract description 8
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 8
- 235000011925 Passiflora alata Nutrition 0.000 claims abstract description 8
- 235000000370 Passiflora edulis Nutrition 0.000 claims abstract description 8
- 235000011922 Passiflora incarnata Nutrition 0.000 claims abstract description 8
- 240000002690 Passiflora mixta Species 0.000 claims abstract description 8
- 235000013750 Passiflora mixta Nutrition 0.000 claims abstract description 8
- 235000013731 Passiflora van volxemii Nutrition 0.000 claims abstract description 8
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 8
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 8
- 239000008280 blood Substances 0.000 claims abstract description 8
- 210000004369 blood Anatomy 0.000 claims abstract description 8
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 8
- 235000008397 ginger Nutrition 0.000 claims abstract description 8
- 241000251511 Holothuroidea Species 0.000 claims abstract description 7
- 241000237502 Ostreidae Species 0.000 claims abstract description 7
- 235000020636 oyster Nutrition 0.000 claims abstract description 7
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 6
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 6
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 6
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 6
- 210000005036 nerve Anatomy 0.000 claims abstract description 4
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract 2
- 239000000843 powder Substances 0.000 claims description 18
- 230000002936 tranquilizing effect Effects 0.000 claims description 13
- 239000011265 semifinished product Substances 0.000 claims description 12
- 235000013361 beverage Nutrition 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 235000009508 confectionery Nutrition 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000000796 flavoring agent Substances 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 239000000945 filler Substances 0.000 claims description 4
- 235000013355 food flavoring agent Nutrition 0.000 claims description 4
- 235000003599 food sweetener Nutrition 0.000 claims description 4
- 239000003765 sweetening agent Substances 0.000 claims description 4
- 240000008866 Ziziphus nummularia Species 0.000 claims description 3
- 230000004087 circulation Effects 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 239000000049 pigment Substances 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 239000007779 soft material Substances 0.000 claims description 3
- 239000000080 wetting agent Substances 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 238000005728 strengthening Methods 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 14
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 7
- 229940079593 drug Drugs 0.000 abstract description 7
- 206010022437 insomnia Diseases 0.000 abstract description 7
- 210000004556 brain Anatomy 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 2
- 230000003860 sleep quality Effects 0.000 abstract description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 15
- 239000002994 raw material Substances 0.000 description 12
- 240000004371 Panax ginseng Species 0.000 description 8
- 210000000582 semen Anatomy 0.000 description 7
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 229940091250 magnesium supplement Drugs 0.000 description 5
- 208000019116 sleep disease Diseases 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 4
- 235000021552 granulated sugar Nutrition 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 108010011485 Aspartame Proteins 0.000 description 3
- 241000168517 Haematococcus lacustris Species 0.000 description 3
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 3
- 239000000605 aspartame Substances 0.000 description 3
- 235000010357 aspartame Nutrition 0.000 description 3
- 229960003438 aspartame Drugs 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 241000965254 Apostichopus japonicus Species 0.000 description 2
- 244000241838 Lycium barbarum Species 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- 235000015468 Lycium chinense Nutrition 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 229960003987 melatonin Drugs 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229940076279 serotonin Drugs 0.000 description 2
- 208000020685 sleep-wake disease Diseases 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 102000004300 GABA-A Receptors Human genes 0.000 description 1
- 108090000839 GABA-A Receptors Proteins 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000008344 brain blood flow Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 235000021433 fructose syrup Nutrition 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 229940053999 hypnotics and sedatives melatonin receptor agonists Drugs 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000014366 other mixer Nutrition 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 229940044601 receptor agonist Drugs 0.000 description 1
- 239000000018 receptor agonist Substances 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000004799 sedative–hypnotic effect Effects 0.000 description 1
- 230000004622 sleep time Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229940069506 theanine 100 mg Drugs 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/362—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Anesthesiology (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明提供了一种能改善睡眠的组合物,属于药物或保健食品领域。所述组合物按重量份数计包含:茶氨酸10‑30份、γ‑氨基丁酸40‑60份、酸枣仁提取物10‑30份、虾青素0.2‑0.3份、葡萄糖酸镁1‑3份。所述组合物还包含:枸杞5‑20份、黄精5‑15份、西番莲5‑10份、桑葚5‑30份、玛咖5‑20份、人参3‑20份、海参肽0.2‑0.5份、牡蛎肽0.1‑0.6份、黑生姜5‑15份、鹿心血1‑5份、肉桂5‑20份。本发明还提供了由所述组合物制备的药物制剂或保健食品及保健品的制备方法。本发明还提供了所述组合物、药物制剂或保健食品的用途。本发明的组合物能够显著改善失眠、提高睡眠质量并具有补脑安神的作用。
Description
技术领域
本发明涉及药物或保健食品领域,特别涉及能改善睡眠药物和保健食品,具体涉及能改善睡眠的组合物、保健食品、药物制剂及其制备方法与应用。
背景技术
随着社会生活的节奏加快和压力增加,越来越多的人面临睡眠障碍的问题,主要表现为入睡困难、睡眠维持困难、睡眠质量下降等,长时间还会引起记忆力和注意力下降等问题,甚至会对免疫系统产生影响,对人的生命健康都造成严重威胁。睡眠障碍的常见起因除了精神压力以外,还包括社会心理因素,或者由某些慢性疾病等引起。睡眠障碍越来越多的出现甚至会影响到人们的正常的工作和学习生活。
目前,用于治疗失眠的药物主要为镇静催眠类药物,常用的药物主要包括苯二氮卓类受体激动剂、褪黑素受体激动剂和具有催眠效果的抗抑郁药物。然而,这些药物会产生不同的依赖性和副作用。除此之外,市面上也有一些治疗失眠的中药类,但是大多都治疗效果欠佳且副作用不明确。并且由于中药的服用煎煮过程复杂耗时、口味较差、服用量较大,所以大多患者对于中药都难以接受。总之,目前的治疗失眠的药物组合物还无法满足广大患者对于失眠以及相关病症的治疗需求。
发明内容
为了解决现有技术中的一个或者多个上述技术问题,本发明在第一方面提供了一种能改善睡眠的组合物,所述组合物包含:茶氨酸、γ-氨基丁酸、酸枣仁提取物、虾青素、葡萄糖酸镁。
具体地,所述组合物按重量份数计包含:茶氨酸10-30份、γ-氨基丁酸40-60份、酸枣仁10-30份、虾青素0.2-0.3份(或3%的雨生红球藻粉6.7-10份)、葡萄糖酸镁1-3份。
更具体地,所述组合物按重量份数计包含:茶氨酸20份、γ-氨基丁酸50份、酸枣仁20份、虾青素0.25份(或3%的雨生红球藻粉8.5份)、葡萄糖酸镁2份。
更具体地,所述组合物包含:茶氨酸200mg、γ-氨基丁酸500mg、酸枣仁200mg、虾青素2.5mg(或3%的雨生红球藻粉85mg)、葡萄糖酸镁20mg。
所述组合物还包含:枸杞、黄精、西番莲、桑葚、玛咖、人参、海参肽、牡蛎肽、黑生姜、鹿心血、肉桂。
具体地,所述组合物按重量份数计还包含:枸杞5-20份、黄精5-15份、西番莲5-10份、桑葚5-30份、玛咖5-20份、人参3-20份、海参肽0.2-0.5份、牡蛎肽0.1-0.6份、黑生姜5-15份、鹿心血1-5份、肉桂5-20份。
更具体地,所述组合物按重量份数计还包含:枸杞15份、黄精10份、西番莲8份、桑葚20份、玛咖10份、人参5份、海参肽0.3份、牡蛎肽0.4份、黑生姜10份、鹿心血3份、肉桂10份。
本发明在第二方面提供了一种能改善睡眠的药物制剂。优选地,所述药物制剂包含本发明第一方面所述的组合物。优选地,药物制剂由本发明第一方面提供的组合物制备而成。
具体地,可以将本发明第一方面提供的组合物直接进行混合,再进一步制备成药物制剂。例如,将所需重量份数的茶氨酸、γ-氨基丁酸、酸枣仁提取物、虾青素、葡萄糖酸镁进行混合。更具体地,将茶氨酸10-30份、γ-氨基丁酸40-60份、酸枣仁提取物10-30份、虾青素0.2-0.3份、葡萄糖酸镁1-3份进行混合。
具体地,将本发明第一方面提供的组合物中的部分原料制备成提取物,将所述提取物与其余原料进行混合,再进一步制备成药物制剂。例如,将所需重量份数的枸杞、黄精、西番莲、桑葚、玛咖、人参、黑生姜、鹿心血、肉桂等进行提取获得提取物,然后将所述提取物与茶氨酸、γ-氨基丁酸、酸枣仁提取物、虾青素、葡萄糖酸镁、海参肽、牡蛎肽等进行混合,再进一步制备成药物制剂。
本发明中的提取物的制备方法可以采用分别提取的方式或混合提取的方式。分别提取即采用将一种原料单独进行提取后,再合并各个原料的提取物。混合提取即将原料混合后一并进行提取。提取方法包括将质量比为1:10-20的原料与水或乙醇混合,加热熬煮,然后过滤,将所得滤液进行浓缩干燥,即得到所述提取物。
所述药物制剂可以为丸剂、片剂、胶囊剂或口服液。
本发明在第三方面提供了一种能改善睡眠的保健食品。所述保健食品由本发明第一方面所述的组合物制备而成。优选地,所述保健食品为大力安神压片糖果或大力安神饮。
所述大力安神压片糖果中还添加下述质量百分比含量的成分:填充剂5-45%和调味剂5-35%。所述填充剂选自硬脂酸镁、麦芽糊精、低聚异麦芽糖和乳糖中的一种或多种。所述调味剂选自三氯蔗糖、柠檬酸、苹果酸、阿斯巴甜、木糖醇、果糖和蔗糖中的一种或多种。
所述大力安神饮中还添加下述质量百分比含量的成分:甜味剂0.5-10%、香精0.5-1%、酸度调节剂0.01-0.5%和食用色素0.001-0.01%,余量为水。所述甜味剂可以选自白砂糖、果葡糖浆、木糖醇、低聚木糖、低聚果糖和阿斯巴甜中的一种或多种。所述酸度调节剂为苹果酸、柠檬酸或醋酸中的一种或多种。所述香精可以选自水果口味香精。
本发明在第四方面提供了一种能改善睡眠的保健食品的制备方法。
具体地提供了一种大力安神压片糖果的制备方法,所述方法包括下述步骤:
A.获得粉末形式的茶氨酸、γ-氨基丁酸、酸枣仁提取物、虾青素、葡萄糖酸镁(可选地将枸杞、黄精、西番莲、桑葚、玛咖、人参、黑生姜、鹿心血、肉桂分别或合并地进行提取获得提取物,干燥后再进行粉碎获得粉末形式,可选地另取粉末形式的海参肽、牡蛎肽);
B.按重量份取茶氨酸、γ-氨基丁酸、酸枣仁提取物、虾青素、葡萄糖酸镁粉末(可选地按重量份另取枸杞、黄精、西番莲、桑葚、玛咖、人参、黑生姜、鹿心血、肉桂等提取物粉末与海参肽粉末、牡蛎肽粉末)与调味剂一起加入混合机进行混合30-60min;
C.加入湿润剂酒精制成软材后,经制粒机进行制粒过筛,之后再使用50-100℃热风循环烘箱干燥2-3h,制得干颗粒;
D.将干颗粒加入填充剂进行混合20-30min,制成半成品;
E.将半成品输入压片机进行压片即得。
具体地还提供了一种大力安神饮的制备方法,所述方法包括下述步骤:
A.按重量份取茶氨酸、γ-氨基丁酸、酸枣仁提取物(市售)、虾青素、葡萄糖酸镁(可选地将枸杞、黄精、西番莲、桑葚、玛咖、人参、黑生姜、鹿心血、肉桂分别或合并地进行提取获得提取液,进行浓缩得到提取液;可选地按重量份另取枸杞、黄精、西番莲、桑葚、玛咖、人参、黑生姜、鹿心血、肉桂提取液与海参肽、牡蛎肽)与甜味剂、香精、酸度调节剂、食用色素和水进行充分混合,可采用高剪切均质机和其它的混合机进行混合,得到半成品;
B.将半成品进行高温灭菌;
C.灭菌后进行灌装,即得。
本发明在第五方面提供了一种能改善睡眠的组合物在制备用于能改善睡眠的药物或者保健食品中的应用。所述组合物为本发明在第一方面提供的组合物。
本发明所采用的主要原料具有如下效果:
茶氨酸是从天然茶叶植物中提取的,茶氨酸可以明显促进脑中枢多巴胺释放,能活化大脑的抑制性神经而抑制兴奋性神经,从而能够起到助眠安眠的功效。茶氨酸还具有提高注意力的功效,可以缓解过劳工作引起的压力,缓解疲劳,改善记忆力。
γ-氨基丁酸(GABA)是一种天然存在的活性氨基酸,是重要的神经递质,具有降血压、改善脑部血液循环、镇静等生理活性。
酸枣仁具有补肝、宁心、敛汗和生津的功效,还具有镇静、催眠、抗惊厥的功效。常用于虚烦不眠、惊悸多梦、卧睡不安、神志不守、易于健忘。
虾青素能够在短时间内改善睡眠不好的状态,使人体力充沛、头脑清醒、浑身有劲,还具有增强记忆、提高免疫力的功效。
镁对大脑是不可或缺的微量元素。镁还是色氨酸转化为血清素再转化为褪黑素过程中的重要辅助物质,缺少镁血清素和自体褪黑素的产生会面临障碍,进而影响入睡的时间,而且还有可能引起身体的其他健康问题。镁可以通过刺激GABA神经元的受体,促使GABA的释放。缺少镁,GABA释放的量和作用都会降低,可能导致缩短睡眠时间和影响睡眠的深度。
本发明正是将这些原料根据中草药传统配方理论和现代制药技术原理进行科学配伍。所制备的产品具有改善睡眠、促进睡眠、安神宁心,还具有抗焦虑、镇静、缓解压力和疲劳的作用。该产品绿色、安全、健康,非常适合患有失眠或其他睡眠障碍的人群服用,还适合工作压力大、易疲劳、易紧张焦虑等人群服用。
具体实施方式
实施例1、大力安神压片糖果,由如下质量的原料制成:
茶氨酸200mg、γ-氨基丁酸500mg、酸枣仁提取物200mg(市售)、虾青素2.5mg、葡萄糖酸镁20mg、采用下述压片糖果的制备方法制备大力安神压片糖果。
所述大力安神压片糖果的制备方法包括下述步骤:
A.获得粉末形式的茶氨酸、γ-氨基丁酸、酸枣仁提取物、虾青素、葡萄糖酸镁;
B.按重量份取茶氨酸、γ-氨基丁酸、酸枣仁提取物、虾青素、葡萄糖酸镁粉末与阿斯巴甜一起加入混合机进行混合45min;
C.加入湿润剂酒精制成软材后,经制粒机进行制粒过筛,之后再使用85℃热风循环烘箱干燥2.5h,制得干颗粒;
D.将干颗粒加入山梨糖醇和硬脂酸镁进行混合30min,制成半成品;
E.将半成品输入压片机进行压片即得。
实施例2、大力安神饮,由如下质量的原料制成:
茶氨酸200mg、γ-氨基丁酸500mg、酸枣仁提取物200mg(市售)、虾青素2.5mg、葡萄糖酸镁20mg、采用适量白砂糖、柠檬酸、余量为纯净水,采用下述饮料制备方法进行制备。
所述大力安神饮的制备方法包括下述步骤:
A.按重量份取茶氨酸、γ-氨基丁酸、酸枣仁提取物、虾青素、葡萄糖酸镁与白砂糖、柠檬酸和纯净水采用高剪切均质机进行充分混合得到半成品;
B.将半成品经121℃高温灭菌20分钟;
C.灭菌后进行灌装,即得。
实施例3、组合物的助眠安神效果
为了验证几种功效成分的组合作用,配置了不同配比组分添加量的组合物,具体组分配比情况如下:
能改善睡眠的组合物一:只添加γ-氨基丁酸500mg;
能改善睡眠的组合物二:添加茶氨酸200mg、γ-氨基丁酸500mg、酸枣仁提取物200mg;
能改善睡眠的组合物三:添加茶氨酸100mg、γ-氨基丁酸500mg、酸枣仁提取物300mg、虾青素2.5mg、葡萄糖酸镁10mg;
能改善睡眠的组合物四:添加茶氨酸200mg、γ-氨基丁酸500mg、酸枣仁提取物200mg、虾青素2.5mg、葡萄糖酸镁20mg;
将以上四组组合物分别制备成大力安神饮,在四组大力安神饮中除了上述原料添加量不同外,其他组分都相同,均为相同含量的适量白砂糖、柠檬酸、余量为纯净水。
分别让60位有睡眠问题的人服用上述四组大力安神饮,连续饮用7日,每日早晚各饮用一次,每次饮用剂量相同,并进行记录饮用后效果。结果如下:
由组合物一制备的大力安神饮:33人饮用后明显改善睡眠情况
由组合物二制备的大力安神饮:39人饮用后明显改善睡眠情况
由组合物三制备的大力安神饮:46人饮用后明显改善睡眠情况
由组合物四制备的大力安神饮:57人饮用后明显改善睡眠情况
由此可见茶氨酸、γ-氨基丁酸、酸枣仁提取物、虾青素、葡萄糖酸镁等组分通过协同增效作用明显提高了改善睡眠的效果,特别是在茶氨酸、γ-氨基丁酸、酸枣仁提取物、虾青素、葡萄糖酸镁的重量份配比为:200:500:200:2.5:20的特定配比下,改善睡眠的效果具有显著的提高。
最后说明的是:以上实施例仅用于说明本发明的技术方案,而非对其限制;尽管参照前述实施例对本发明进行了详细说明,本领域普通技术人员应当理解:其依然可以对各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换;而这些修改或者替换,并不使技术方案的本质脱离本发明各实施例的技术方案的精神和范围。
Claims (10)
1.一种能改善睡眠的组合物,其特征在于:所述组合物按重量份数计包含:茶氨酸10-30份、γ-氨基丁酸40-60份、酸枣仁提取物10-30份、虾青素0.2-0.3份、葡萄糖酸镁1-3份。
2.如权利要求1所述的能改善睡眠的组合物,其特征在于:所述组合物按重量份数计包含:茶氨酸20份、γ-氨基丁酸50份、酸枣仁提取物20份、虾青素0.25份、葡萄糖酸镁2份。
3.如权利要求1所述的能改善睡眠的组合物,其特征在于:所述组合物按重量份数计还包含:枸杞5-20份、黄精5-15份、西番莲5-10份、桑葚5-30份、玛咖5-20份、人参3-20份、海参肽0.2-0.5份、牡蛎肽0.1-0.6份、黑生姜5-15份、鹿心血1-5份、肉桂5-20份。
4.一种能改善睡眠的药物制剂,其特征在于:所述药物制剂由权利要求1~3任一项所述的组合物制备而成。
5.如权利要求4所述的能改善睡眠的药物制剂,其特征在于:所述药物制剂为丸剂、片剂、胶囊剂或口服液。
6.一种能改善睡眠的保健食品,其特征在于:所述保健食品由权利要求1~3任一项所述的组合物制备而成。
7.如权利要求6所述的能改善睡眠的保健食品,所述保健食品为大力安神压片糖果或大力安神饮。
8.一种制备大力安神压片糖果的方法,所述方法包括以下步骤:
A.获得粉末形式的茶氨酸、γ-氨基丁酸、酸枣仁提取物、虾青素、葡萄糖酸镁;
B.按重量份取茶氨酸粉末10-30份、γ-氨基丁酸粉末40-60份、酸枣仁提取物粉末10-30份、虾青素粉末0.2-0.3份、葡萄糖酸镁粉末1-3份与调味剂一起加入混合机进行混合30-60min;
C.加入湿润剂酒精制成软材后,经制粒机进行制粒过筛,之后再使用50-100℃热风循环烘箱干燥2-3h,制得干颗粒;
D.将干颗粒加入填充剂进行混合20-30min,制成半成品;
E.将半成品输入压片机进行压片即得。
9.一种制备大力安神饮的方法,所述方法包括以下步骤:
A.按重量份取茶氨酸10-30份、γ-氨基丁酸40-60份、酸枣仁提取物10-30份、虾青素0.2-0.3份、葡萄糖酸镁1-3份与甜味剂、香精、酸度调节剂、食用色素和水进行充分混合,得到半成品;
B.将半成品进行高温灭菌;
C.灭菌后进行灌装,即得。
10.权利要求1-3所述的组合物在制备用于能改善睡眠的药物或者保健食品中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011060590.9A CN112205507A (zh) | 2020-09-30 | 2020-09-30 | 一种能改善睡眠的组合物、保健食品、药物制剂及其制备方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011060590.9A CN112205507A (zh) | 2020-09-30 | 2020-09-30 | 一种能改善睡眠的组合物、保健食品、药物制剂及其制备方法与应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112205507A true CN112205507A (zh) | 2021-01-12 |
Family
ID=74051664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011060590.9A Pending CN112205507A (zh) | 2020-09-30 | 2020-09-30 | 一种能改善睡眠的组合物、保健食品、药物制剂及其制备方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112205507A (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112841478A (zh) * | 2021-01-28 | 2021-05-28 | 陕西健驰生物药业有限公司 | 一种改善睡眠的植物饮料及其制备方法 |
CN112869162A (zh) * | 2021-02-08 | 2021-06-01 | 宁波御坊堂生物科技有限公司 | 一种具有抗疲劳、改善睡眠功能的组合物及制备方法 |
CN113973965A (zh) * | 2021-10-29 | 2022-01-28 | 上海圣岳生物科技有限公司 | 含茶氨酸复合物使人心情放松的压片糖果及其制备方法 |
CN114376039A (zh) * | 2021-12-25 | 2022-04-22 | 宁波荟康生命科技有限公司 | 一种用于安神、改善睡眠的复合果茶及其制备方法 |
CN114766670A (zh) * | 2022-05-18 | 2022-07-22 | 王民珏 | 具有助眠功能的特殊膳食食品配方 |
CN115024491A (zh) * | 2022-06-10 | 2022-09-09 | 百威(武汉)啤酒有限公司 | 助睡眠的组合物及应用,含有该组合物的饮料及制备方法 |
WO2022226706A1 (zh) * | 2021-04-25 | 2022-11-03 | 王佳皓 | 改善睡眠质量的组合物、药物制剂、保健食品及应用 |
CN115363204A (zh) * | 2022-08-31 | 2022-11-22 | 蔡福带 | 一种补气血助眠口服液及其制备方法 |
CN116195744A (zh) * | 2023-03-21 | 2023-06-02 | 杨继辉 | 用于干预焦虑引起的睡眠障碍的营养配方 |
CN117256865A (zh) * | 2023-10-12 | 2023-12-22 | 上海诺德生物实业有限公司 | 一种具有改善睡眠作用的茶叶茶氨酸组合物及其制备方法与应用 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080044499A1 (en) * | 2004-04-06 | 2008-02-21 | Taiyokagaku Co., Ltd. | Sleep Improvement Composition |
KR100947353B1 (ko) * | 2009-09-11 | 2010-03-15 | 김영식 | 수면장애 개선과 쾌면을 위한 건강식품 조성물 |
CN103110709A (zh) * | 2011-11-16 | 2013-05-22 | 北京康比特体育科技股份有限公司 | 一种改善睡眠的组合物及其制备方法 |
CN103784611A (zh) * | 2014-01-23 | 2014-05-14 | 云南白药天颐茶品有限公司 | 一种具有改善睡眠帮助缓解压力的组合物及其应用 |
CN105029417A (zh) * | 2015-08-26 | 2015-11-11 | 苏州泽达兴邦医药科技有限公司 | 一种用于改善睡眠的保健食品及其生产工艺 |
CN106309605A (zh) * | 2016-10-08 | 2017-01-11 | 广东太阳神集团有限公司 | 一种具有改善睡眠功能的保健食品及其制备方法 |
CN109820905A (zh) * | 2019-03-06 | 2019-05-31 | 北京坤秋健康科技有限公司 | 一种治疗失眠的药物组合物及其应用 |
CN110882245A (zh) * | 2019-12-16 | 2020-03-17 | 厦门市健康医疗大数据中心(厦门市医药研究所) | 一种改善睡眠的组合物及其用途 |
-
2020
- 2020-09-30 CN CN202011060590.9A patent/CN112205507A/zh active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080044499A1 (en) * | 2004-04-06 | 2008-02-21 | Taiyokagaku Co., Ltd. | Sleep Improvement Composition |
KR100947353B1 (ko) * | 2009-09-11 | 2010-03-15 | 김영식 | 수면장애 개선과 쾌면을 위한 건강식품 조성물 |
CN103110709A (zh) * | 2011-11-16 | 2013-05-22 | 北京康比特体育科技股份有限公司 | 一种改善睡眠的组合物及其制备方法 |
CN103784611A (zh) * | 2014-01-23 | 2014-05-14 | 云南白药天颐茶品有限公司 | 一种具有改善睡眠帮助缓解压力的组合物及其应用 |
CN105029417A (zh) * | 2015-08-26 | 2015-11-11 | 苏州泽达兴邦医药科技有限公司 | 一种用于改善睡眠的保健食品及其生产工艺 |
CN106309605A (zh) * | 2016-10-08 | 2017-01-11 | 广东太阳神集团有限公司 | 一种具有改善睡眠功能的保健食品及其制备方法 |
CN109820905A (zh) * | 2019-03-06 | 2019-05-31 | 北京坤秋健康科技有限公司 | 一种治疗失眠的药物组合物及其应用 |
CN110882245A (zh) * | 2019-12-16 | 2020-03-17 | 厦门市健康医疗大数据中心(厦门市医药研究所) | 一种改善睡眠的组合物及其用途 |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112841478A (zh) * | 2021-01-28 | 2021-05-28 | 陕西健驰生物药业有限公司 | 一种改善睡眠的植物饮料及其制备方法 |
CN112869162A (zh) * | 2021-02-08 | 2021-06-01 | 宁波御坊堂生物科技有限公司 | 一种具有抗疲劳、改善睡眠功能的组合物及制备方法 |
CN112869162B (zh) * | 2021-02-08 | 2023-03-10 | 浙江大医德美生物科技有限公司 | 一种具有抗疲劳、改善睡眠功能的组合物及制备方法 |
WO2022226706A1 (zh) * | 2021-04-25 | 2022-11-03 | 王佳皓 | 改善睡眠质量的组合物、药物制剂、保健食品及应用 |
CN113973965A (zh) * | 2021-10-29 | 2022-01-28 | 上海圣岳生物科技有限公司 | 含茶氨酸复合物使人心情放松的压片糖果及其制备方法 |
CN113973965B (zh) * | 2021-10-29 | 2023-10-13 | 上海圣岳生物科技有限公司 | 含茶氨酸复合物使人心情放松的压片糖果及其制备方法 |
CN114376039A (zh) * | 2021-12-25 | 2022-04-22 | 宁波荟康生命科技有限公司 | 一种用于安神、改善睡眠的复合果茶及其制备方法 |
CN114766670A (zh) * | 2022-05-18 | 2022-07-22 | 王民珏 | 具有助眠功能的特殊膳食食品配方 |
CN115024491A (zh) * | 2022-06-10 | 2022-09-09 | 百威(武汉)啤酒有限公司 | 助睡眠的组合物及应用,含有该组合物的饮料及制备方法 |
CN115363204A (zh) * | 2022-08-31 | 2022-11-22 | 蔡福带 | 一种补气血助眠口服液及其制备方法 |
CN115363204B (zh) * | 2022-08-31 | 2023-11-17 | 蔡福带 | 一种补气血助眠口服液及其制备方法 |
CN116195744A (zh) * | 2023-03-21 | 2023-06-02 | 杨继辉 | 用于干预焦虑引起的睡眠障碍的营养配方 |
CN117256865A (zh) * | 2023-10-12 | 2023-12-22 | 上海诺德生物实业有限公司 | 一种具有改善睡眠作用的茶叶茶氨酸组合物及其制备方法与应用 |
CN117256865B (zh) * | 2023-10-12 | 2024-03-15 | 上海诺德生物实业有限公司 | 一种具有改善睡眠作用的茶叶茶氨酸组合物及其制备方法与应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112205507A (zh) | 一种能改善睡眠的组合物、保健食品、药物制剂及其制备方法与应用 | |
CN103784611B (zh) | 一种具有改善睡眠帮助缓解压力的组合物及其应用 | |
CN101961062B (zh) | 参芪美容茶及其生产制备方法 | |
US20130171276A1 (en) | Composition Comprising Cudrania Tricuspidata and Coix Lachryma-Jobi for Suppressing Obesity or Lowering Blood Sugar, and Use Thereof | |
CN101822704B (zh) | 一种祛斑药物组合物及其制备方法 | |
CN107536920A (zh) | 一种治疗周围神经炎的组合物、其制备方法和应用 | |
US20160199427A1 (en) | Food, beverage or pharmaceutical composition containing fermented eastern prickly pear and a preparation method therefor | |
CN110613078A (zh) | 助睡眠的固体饮料及其制备方法 | |
KR20130086459A (ko) | 산조인 추출물을 유효성분으로 함유하는 속효성 우울증 예방 및 치료용 약학적 조성물 | |
CN112568397A (zh) | 一种可改善睡眠的蓝莓粉复方固体制剂及其制备方法和应用 | |
CN101543248A (zh) | 一种特别适合“三高一酸”人群饮用的凉茶及其制备方法 | |
CN114028514B (zh) | 一种具有改善记忆作用枸杞子药食两用组合物及其制备方法与应用 | |
CN103349121B (zh) | 降三高保健茶及其制备方法 | |
CN111149910A (zh) | 一种双参口香糖及其制备方法 | |
CN114190500A (zh) | 一种改善睡眠的植物饮料及其制备方法 | |
CN111840394B (zh) | 一种用于失眠的药物组合物及其制备方法 | |
CN112618608A (zh) | 具有解酒功能的组合物及其制备方法和应用 | |
CN110810601A (zh) | 一种速溶党参咖啡及其制备方法 | |
KR20100025303A (ko) | 인삼 사포닌의 기능이 강화된 기능성 음료 조성물 | |
CN101190250B (zh) | 一种防治高原病的咀嚼片及其制备方法 | |
CN111135235A (zh) | 一种预防和缓解急性酒精中毒或醉酒的组合物 | |
CA2807453A1 (en) | Anti-fatigue composition of plant material and preparation method, use and products thereof | |
CN110179931B (zh) | 一种养心安神组合物及其制备方法 | |
CN108379500B (zh) | 一种养肝解酒醒酒防口臭的麦苗中药组合物及制备方法 | |
CN104222400A (zh) | 醒酒护肝、宁心安神的普洱茶膏及其加工方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210112 |